Prot # LJ501-CRH01: A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients with Catecholamine-Resistant Hypotension (CRH)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/30/154/5/18

Funding

  • La Jolla Pharmaceutical Company (Prot # LJ501-CRH01)